Citadel Advisors
TWST icon

Citadel Advisors’s Twist Bioscience TWST Stock Holding History

Citadel Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.63M Buy
55,400
+23,200
+72% +$1.04M ﹤0.01% 5517
2025
Q4 		$1.02M Sell
32,200
-6,300
-16% -$197K ﹤0.01% 7350
2025
Q3 		$1.08M Buy
38,500
+10,700
+38% +$324K ﹤0.01% 7366
2025
Q2 		$1.02M Buy
27,800
+5,900
+27% +$204K ﹤0.01% 7039
2025
Q1 		$860K Buy
21,900
+12,800
+141% +$577K ﹤0.01% 7300
2024
Q4 		$423K Buy
9,100
+4,300
+90% +$194K ﹤0.01% 8931
2024
Q3 		$217K Sell
4,800
-6,500
-58% -$309K ﹤0.01% 9981
2024
Q2 		$557K Sell
11,300
-7,100
-39% -$290K ﹤0.01% 7839
2024
Q1 		$631K Sell
18,400
-67,700
-79% -$2.44M ﹤0.01% 7874
2023
Q4 		$3.17M Buy
86,100
+44,200
+105% +$1.02M ﹤0.01% 4542
2023
Q3 		$849K Sell
41,900
-36,900
-47% -$811K ﹤0.01% 6914
2023
Q2 		$1.61M Buy
78,800
+45,500
+137% +$682K ﹤0.01% 5551
2023
Q1 		$502K Buy
33,300
+20,800
+166% +$459K ﹤0.01% 8299
2022
Q4 		$298K Buy
12,500
+6,100
+95% +$177K ﹤0.01% 9339
2022
Q3 		$226K Sell
6,400
-7,300
-53% -$310K ﹤0.01% 10160
2022
Q2 		$479K Sell
13,700
-10,000
-42% -$354K ﹤0.01% 8745
2022
Q1 		$1.17M Buy
23,700
+1,300
+6% +$72K ﹤0.01% 7350
2021
Q4 		$1.73M Buy
22,400
+2,800
+14% +$287K ﹤0.01% 6581
2021
Q3 		$2.1M Sell
19,600
-3,400
-15% -$389K ﹤0.01% 6239
2021
Q2 		$3.06M Sell
23,000
-16,100
-41% -$1.87M ﹤0.01% 5551
2021
Q1 		$4.84M Buy
39,100
+7,500
+24% +$1.14M ﹤0.01% 4321
2020
Q4 		$4.46M Buy
31,600
+22,100
+233% +$2.45M ﹤0.01% 3872
2020
Q3 		$722K Buy
9,500
+4,300
+83% +$268K ﹤0.01% 6629
2020
Q2 		$236K Buy
+5,200
New +$187K ﹤0.01% 8287

Other funds holding TWST

Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citadel Advisors's TWST Position: Q1 2026 in Review

Citadel Advisors increased its Twist Bioscience (TWST) stake by 3,708% in Q1 2026, buying an estimated $53.3M and bringing the position to 1,220,400 shares worth $58M. The position accounts for 0.01% of the portfolio, ranked #1226.

Citadel Advisors first reported a position in TWST in Q3 2019 and has held it in 26 quarters since. The position peaked at $70.4M in Q2 2024. 279 funds tracked by Wall St. Rank hold TWST as of Q1 2026.

  • Citadel Advisors held 1,220,400 shares of Twist Bioscience worth $58M as of Q1 2026.
  • Citadel Advisors bought 1,188,351 Twist Bioscience shares in Q1 2026, an estimated $53.3M.
  • Twist Bioscience made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #1226 holding.
  • Citadel Advisors first reported a position in Twist Bioscience in Q3 2019 and has held it in 26 quarters since.
  • Citadel Advisors's Twist Bioscience position peaked at $70.4M in Q2 2024.
  • 279 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.